ArticleTherapeutic advances in medical oncology2025

Pan-immune-inflammation value as a novel predictor of pathological response to neoadjuvant chemotherapy combined with anti-PD-1 therapy in esophageal squamous cell carcinoma: a multicenter real-world retrospective clinical study.

Jiang-Shan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.